Aug 2 (Reuters) - Novartis AG NOVN.S :
* NOVARTIS PHARMACEUTICALS CANADA SAYS HEALTH CANADA APPROVED AIMOVIG FOR PREVENTION OF MIGRAINE IN ADULTS WHO HAVE AT LEAST 4 MIGRAINE DAYS PER MONTH
Aug 2 (Reuters) - Novartis AG NOVN.S :
* NOVARTIS PHARMACEUTICALS CANADA SAYS HEALTH CANADA APPROVED AIMOVIG FOR PREVENTION OF MIGRAINE IN ADULTS WHO HAVE AT LEAST 4 MIGRAINE DAYS PER MONTH